FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Morphine plasmatic concentration in a pregnant mare and its ...
BMC veterinary research2020; 16(1); 19; doi: 10.1186/s12917-020-2242-9

Morphine plasmatic concentration in a pregnant mare and its foal after long term epidural administration.

Abstract: Epidural administration of morphine has been shown to be an effective analgesic strategy in horses; however, the possible occurrence of side effects limits its usage. In order to decrease their frequency, it is important to target the minimal effective plasma concentration and avoid overdosing. As to date species-specific pharmacokinetics data are not available for epidural morphine, the dosing regimen is usually established on the basis of clinical reports and personal experience. In certain physiological conditions, like gestation, the outcome of an empirical dosing scheme can be unpredictable. The aim of this case report is to describe the pharmacological profile of morphine and its metabolites after prolonged epidural administration in a pregnant mare and her foal. Methods: A 20 years old pregnant mare was presented to our hospital because of severe lameness, 2 months before delivery. Following an ineffective systemic pain treatment, an epidural catheter was inserted and morphine administered (initial dose 0.1 mg/kg every 8 h). Due to its efficacy in controlling pain, it was continued until end of gestation. Plasmatic concentration of morphine and its metabolites were assessed in the mare 6 weeks after starting the treatment, and in both the mare and foal during the first days after delivery. Plasmatic values similar to those previously reported in the literature following morphine short term administration through various routes and not accompanied by side effects were found in the mare, except during an excitatory period. Moreover, no evidence of dangerous drug accumulation or significant milk passage was noticed in the foal. Mild reduction of feces production with no signs of colic and two self-limiting episodes of excitement occurred during treatment in the mare. No side effects occurred during gestation and first phases of life in the foal. Conclusions: Prolonged epidural administration of morphine in a pregnant mare allowed good pain control in absence of clinically relevant side effects, in both the mare and her foal. Sudden increase in morphine plasmatic concentration can occur and side effects appear; careful treatment to the lowest effective dose and continuous monitoring of the clinical condition of the treated horse should be performed.
Get Full Text
Publication Date: 2020-01-20 PubMed ID: 31959188PubMed Central: PMC6971975DOI: 10.1186/s12917-020-2242-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on the study of morphine’s impact on a pregnant horse and its foal following long-term epidural administration, investigating the effectiveness and side effects.

Introduction

  • The paper starts by discussing the efficacy of morphine as an analgesic agent in horses when administered epidurally. However, the usage is limited due to the potential side effects.
  • It mentions the importance of balancing the minimal effective plasma concentration of morphine to avoid overdosing, especially in uncertain physiological conditions like pregnancy.

Objective

  • The study aims to examine the pharmacological profile of morphine and its by-products in a pregnant mare and her foal after long-term epidural administration.

Methodology

  • In the study, a pregnant mare of 20 years suffering from severe lameness was administered morphine epidurally. After an initial unsuccessful trial, the mare received morphine at frequent intervals which continued till the end of her gestation period.
  • The research monitored the plasma concentration of morphine and its metabolites in the mare for six weeks from the start of the treatment and in the mare and her foal post-delivery.

Findings

  • The findings reveal no significant side effects in the mare and her foal. The plasma concentration of morphine in the mare was comparable with those reported for short-term administration via various methods and were without side effects, except during an excitatory phase.
  • The study found no evidence of substantial drug accumulation or significant transfer into milk in the foal.

Conclusion

  • The research concludes that long-term epidural administration of morphine in a pregnant mare resulted in effective pain control devoid of clinically significant side effects in both the mare and her foal.
  • It also warns of the possible sudden spike in morphine plasma concentration and suggests that treatment should be kept to the lowest effective dose while continually monitoring the horse’s clinical condition.

Cite This Article

APA
Mirra A, Birras J, Diez Bernal S, Spadavecchia C. (2020). Morphine plasmatic concentration in a pregnant mare and its foal after long term epidural administration. BMC Vet Res, 16(1), 19. https://doi.org/10.1186/s12917-020-2242-9

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 16
Issue: 1
Pages: 19

Researcher Affiliations

Mirra, Alessandro
  • Department of Clinical Veterinary Medicine, Anaesthesiology and Pain Therapy Section, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012, Bern, Switzerland. alessandro.mirra@vetsuisse.unibe.ch.
Birras, Jasmin
  • Swiss Institute for Equine Medicine (ISME), Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, and Agroscope, Bern, Switzerland.
Diez Bernal, Sabina
  • Department of Clinical Veterinary Medicine, Anaesthesiology and Pain Therapy Section, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012, Bern, Switzerland.
Spadavecchia, Claudia
  • Department of Clinical Veterinary Medicine, Anaesthesiology and Pain Therapy Section, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, 3012, Bern, Switzerland.

MeSH Terms

  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / therapeutic use
  • Animals
  • Animals, Newborn / blood
  • Female
  • Horses
  • Injections, Epidural / veterinary
  • Lameness, Animal / drug therapy
  • Morphine / administration & dosage
  • Morphine / adverse effects
  • Morphine / blood
  • Morphine / therapeutic use
  • Morphine Derivatives / blood
  • Pain / prevention & control
  • Pain / veterinary
  • Pregnancy
  • Tendinopathy / veterinary

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 31 references
  1. Valverde A, Little CB, Dyson DH, Motter CH. Use of epidural morphine to relieve pain in a horse.. Can Vet J 1990;31:211–212.
    pmc: PMC1480787pubmed: 17423538
  2. Goodrich LR, Nixon AJ, Fubini SL, Ducharme NG, Fortier LA, Warnick LD, Ludders JW. Epidural morphine and detomidine decreases postoperative hindlimb lameness in horses after bilateral stifle arthroscopy.. Vet Surg 2002;31:232–239.
    doi: 10.1053/jvet.2002.32436pubmed: 11994850google scholar: lookup
  3. Rodrigo-Mocholi D, Steblaj B, Vlaminck L, Gasthuys F, Schauvliege S. Continuous caudal epidural analgesia for perioperative pain control after bilateral mastectomy in a mare.. Vet Rec Case Rep 2016;4:e000275.
    doi: 10.1136/vetreccr-2015-000275google scholar: lookup
  4. Figueiredo JP, Muir WW, Sams R. Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses.. Am J Vet Res 2012;73:799–808.
    doi: 10.2460/ajvr.73.6.799pubmed: 22620693google scholar: lookup
  5. Martin-Flores M, Campoy L, Kinsley MA, Mohammed HO, Gleed RD, Cheetham J. Analgesic and gastrointestinal effects of epidural morphine in horses after laparoscopic cryptorchidectomy under general anesthesia.. Vet Anaesth Analg 2014;41:430–437.
    doi: 10.1111/vaa.12133pubmed: 24576158google scholar: lookup
  6. Sysel AM, Pleasant RS, Jacobson JD, Moll HD, Warnick LD, Sponenberg DP, Eyre P. Systemic and local effects associated with long-term epidural catheterization and morphine-detomidine administration in horses.. Vet Surg 1997;26:141–149.
    doi: 10.1111/j.1532-950X.1997.tb01477.xpubmed: 9068165google scholar: lookup
  7. Knych HK, Steffey EP, McKemie DS. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.. J Vet Pharmacol Ther 2014;37:374–381.
    doi: 10.1111/jvp.12098pubmed: 24479785google scholar: lookup
  8. Osborne R, Thompson P, Joel S, Trew D, Patel N, Slevin M. The analgesic activity of morphine-6-glucuronide.. Br J clin Pharmac 1992;34:130–138.
    doi: 10.1111/j.1365-2125.1992.tb04121.xpmc: PMC1381529pubmed: 1419474google scholar: lookup
  9. Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H. Analgesic effect of morphine Glucuronides.. Tohoku J Exp Med 1971;105:45–52.
    doi: 10.1620/tjem.105.45pubmed: 5140097google scholar: lookup
  10. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide--a potent antagonist of morphine analgesia.. Life Sci 1990;47(6):579–585.
    doi: 10.1016/0024-3205(90)90619-3pubmed: 2402182google scholar: lookup
  11. Hemstapat K, Monteith GR, Smith D, Smith MH. Morphine-3-Glucuronide’s Neuro-excitatory effects are mediated via indirect activation of N-methyl-d-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal Neurones.. Anesth Analg 2003;97:494–505.
    doi: 10.1213/01.ANE.0000059225.40049.99pubmed: 12873944google scholar: lookup
  12. Gleerup KB, Forkman B, Lindegaard C, Andersen PH. An equine pain face.. Vet Anaesth Analg 2015;42(1):103–114.
    doi: 10.1111/vaa.12212pmc: PMC4312484pubmed: 25082060google scholar: lookup
  13. Natalini CC. Plasma and cerebrospinal fluid alfentanil, butorphanol, and morphine concentrations following caudal epidural administration in horses.. Ciência Rural 2006;36:1436–1443.
    doi: 10.1590/S0103-84782006000500014google scholar: lookup
  14. Frölich N, Dees C, Paetz C, Ren X, Lohse MJ, Nikolaev VO, Zenk MH. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.. Biochem Pharmacol 2011;81(10):1248–1254.
    doi: 10.1016/j.bcp.2011.03.001pubmed: 21396918google scholar: lookup
  15. Lötsch J, Geisslinger G. Morphine-6-glucuronide: an analgesic of the future?. Clin Pharmacokinet 2001;40(7):485–499.
    doi: 10.2165/00003088-200140070-00001pubmed: 11510626google scholar: lookup
  16. Mercadante S. The role of morphine glucuronides in cancer pain.. Palliat Med 1999;13(2):95–104.
    doi: 10.1191/026921699678158579pubmed: 10474692google scholar: lookup
  17. Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist.. Life Sci 1987;41(26):2845–2849.
    doi: 10.1016/0024-3205(87)90431-0pubmed: 2826951google scholar: lookup
  18. Hand CW, Blunnie WP, Claffey LP, McShane AJ, McQuay HJ, Moore RA. Potential analgesic contribution from morphine-6-glucuronide in CSF.. Lancet 1987;2(8569):1207–1208.
    doi: 10.1016/S0140-6736(87)91341-9pubmed: 2890828google scholar: lookup
  19. Mignat C, Wille U, Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.. Life Sci 1995;56(10):793–799.
    doi: 10.1016/0024-3205(95)00010-4pubmed: 7885194google scholar: lookup
  20. Gong QL, Hedner T, Hedner J, Björkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide.. Eur J Pharmacol 1991;193(1):47–56.
    doi: 10.1016/0014-2999(91)90199-Zpubmed: 2050192google scholar: lookup
  21. Ulens C, Baker L, Ratka A, Waumans D, Tytgat J. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.. Biochem Pharmacol 2001;62(9):1273–1282.
    doi: 10.1016/S0006-2952(01)00761-4pubmed: 11705461google scholar: lookup
  22. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight.. Addiction 1997;92(11):1571–1579.
    doi: 10.1111/j.1360-0443.1997.tb02877.xpubmed: 9519499google scholar: lookup
  23. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal.. Am J Obstet Gynecol 1977;127(2):199–201.
    doi: 10.1016/S0002-9378(16)33250-1pubmed: 831502google scholar: lookup
  24. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.. BJOG 2009;116(5):665–671.
    doi: 10.1111/j.1471-0528.2008.02073.xpubmed: 19220239google scholar: lookup
  25. Burns L, Conroy E, Mattick RP. Infant mortality among women on a methadone program during pregnancy.. Drug Alcohol Rev 2010;29(5):551–556.
    doi: 10.1111/j.1465-3362.2010.00176.xpubmed: 20887580google scholar: lookup
  26. Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes.. J Addict Dis 2010;29(2):245–258.
    doi: 10.1080/10550881003684871pubmed: 20407980google scholar: lookup
  27. Hudak ML, Tan RC. Neonatal Drug Withdrawal.. PEDIATRICS 2012;129(2):e540–e560.
    doi: 10.1542/peds.2011-3212pubmed: 22291123google scholar: lookup
  28. Feilberg VL, Rosenborg D, Broen Christensen C, Mogensen JV. Excretion of morphine in human breast milk.. Acta Anaesthesiol Scand 1989;33(5):426–428.
    doi: 10.1111/j.1399-6576.1989.tb02938.xpubmed: 2800981google scholar: lookup
  29. Zakowski MI, Ramanathan S, Turndorf H. A two-dose epidural morphine regimen in cesarean section patients: pharmacokinetic profile.. Acta Anaesthesiol Scand 1993;37(6):584–589.
    doi: 10.1111/j.1399-6576.1993.tb03769.xpubmed: 8213024google scholar: lookup
  30. Ansari J, Carvalho B, Shafer SL, Flood P. Pharmacokinetics and pharmacodynamics of drugs commonly used in pregnancy and parturition.. Anesth Analg 2016;122(3):786–804.
    doi: 10.1213/ANE.0000000000001143pubmed: 26891392google scholar: lookup
  31. Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.. Br J Anaesth 2014;113(6):935–944.
    doi: 10.1093/bja/aeu186pubmed: 24985077google scholar: lookup

Citations

This article has been cited 1 times.
  1. Douglas H, Midon M, Shroff K, Floriano D, Driessen B, Hopster K. Caudal epidural catheterization for pain management in 48 hospitalized horses: A descriptive study of demographics, complications, and outcomes. Front Vet Sci 2022;9:995299.
    doi: 10.3389/fvets.2022.995299pubmed: 36387394google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.